Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Jolly

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Biotechnology Therapeutics|January 1, 1991
Induction of anti-HIV-1 immune responses by retroviral vectorsD J Jolly, J F Warner
The Biochemical Journal|December 1, 1972
Light-scattering studies on deoxyribonucleic acid flexibility. The solution properties of a small circular deoxyribonucleic acid moleculeD J Jolly, A M Campbell
Cancer Gene Therapy|November 4, 2000
Long-term follow-up of retroviral vector-administered interferon-gamma (IFN-gamma) gene in metastatic melanomaJ Nemunaitis, A Buchanan, D J Jolly
Methods in Enzymology|January 1, 1987
High-efficiency gene transfer into cellsD J Jolly, J K Yee, T Friedmann
Molecular and Cellular Biology|April 1, 1986
Variable stability of a selectable provirus after retroviral vector gene transfer into human cellsD J Jolly, R C Willis, T Friedmann
Current Topics in Microbiology and Immunology|February 28, 1998
Human immunodeficiency virus immunotherapy using a retroviral vectorJ F Warner, D J Jolly, J Merritt
Differentiation; Research in Biological Diversity|January 1, 1984
Swimming behavior of X and Y human spermS Sarkar, D J Jolly, T Friedmann, et al.
Biochimica Et Biophysica Acta|March 10, 2000
HIV protease as a target for retrovirus vector-mediated gene therapyS Todd, C Anderson, D J Jolly, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 3, 2001
Toxicity assessment of intratumoral injection of the herpes simplex type I thymidine kinase gene delivered by retrovirus in patients with refractory cancerS Singh, C Cunningham, A Buchanan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1983
A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRTA D Miller, D J Jolly, T Friedmann, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Biotechnology Therapeutics|January 1, 1991
Induction of anti-HIV-1 immune responses by retroviral vectorsD J Jolly, J F Warner
The Biochemical Journal|December 1, 1972
Light-scattering studies on deoxyribonucleic acid flexibility. The solution properties of a small circular deoxyribonucleic acid moleculeD J Jolly, A M Campbell
Cancer Gene Therapy|November 4, 2000
Long-term follow-up of retroviral vector-administered interferon-gamma (IFN-gamma) gene in metastatic melanomaJ Nemunaitis, A Buchanan, D J Jolly
Methods in Enzymology|January 1, 1987
High-efficiency gene transfer into cellsD J Jolly, J K Yee, T Friedmann
Molecular and Cellular Biology|April 1, 1986
Variable stability of a selectable provirus after retroviral vector gene transfer into human cellsD J Jolly, R C Willis, T Friedmann
Current Topics in Microbiology and Immunology|February 28, 1998
Human immunodeficiency virus immunotherapy using a retroviral vectorJ F Warner, D J Jolly, J Merritt
Differentiation; Research in Biological Diversity|January 1, 1984
Swimming behavior of X and Y human spermS Sarkar, D J Jolly, T Friedmann, et al.
Biochimica Et Biophysica Acta|March 10, 2000
HIV protease as a target for retrovirus vector-mediated gene therapyS Todd, C Anderson, D J Jolly, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 3, 2001
Toxicity assessment of intratumoral injection of the herpes simplex type I thymidine kinase gene delivered by retrovirus in patients with refractory cancerS Singh, C Cunningham, A Buchanan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1983
A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRTA D Miller, D J Jolly, T Friedmann, et al.
Pageof 7